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Innate immunity is the fi  rst line of defense against 
pathogenic microorganisms. Toll-like receptors 
(TLRs) (1–6) play a critical role in innate immune 
responses in mammals through the recognition 
of conserved molecular patterns associated with 
diff  erent microorganisms. Although TLR4 has 
been genetically identifi  ed as a signaling mole-
cule essential for the responses to LPS, a com-
ponent of gram-negative bacteria (7), TLR2 
responds to mycobacteria, yeast, and gram-
  positive bacteria (8–11). TLR6 associates with 
TLR2 and recognizes lipoproteins from mico-
plasma. TLR5 and TLR9 mediates the induc-
tion of the immune response by bacterial fl  agellins 
(12) and bacterial DNA (5), respectively. Although 
TLR3 recognizes double-stranded RNA (13), 
single-stranded RNA is the natural ligand for 
TLR7/8 (14, 15). The natural ligands for TLR10 
and TLR11 are still not known (6).
Upon binding of TLR ligands, all of the 
TLRs except TLR3 recruit the adaptor molecule 
MyD88 through the TIR domain, mediating 
the so-called MyD88-dependent pathway (16). 
MyD88 then recruits serine-threonine kinases 
IL-1R–associated kinase (IRAK)4 (17–19) 
and IRAK (20, 21). Although IRAK4 is the 
kinase that functions upstream of and phos-
phorylates IRAK, the phosphorylated IRAK 
mediates the recruitment of TRAF6 to the re-
ceptor complex (22). Upon phosphorylation of 
IRAK, the IRAK–TRAF6 complex dissoci-
ates from the receptor complex to interact with 
and activate TGF-β–activated kinase 1 (TAK1), 
a member of the mitogen-activated protein ki-
nase kinase kinase family (23). The activation 
of TAK1 eventually leads to the activation of 
NF-κB and c-Jun NH2-terminal kinase (JNK) 
(24), resulting in induction of infl  ammatory cyto-
kines and chemokines such as TNF-α, IL-1β, 
IL-6, and IL-8.
Recent studies have begun to unravel how 
a subset of TLRs, TLR7, TLR8, and TLR9 
use a novel MyD88-dependent pathway to 
mediate the activation of transcription factors 
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IRAK4 is a member of IL-1 receptor (IL-1R)–associated kinase (IRAK) family and has been 
shown to play an essential role in Toll-like receptor (TLR)–mediated signaling. We recently 
generated IRAK4 kinase-inactive knock-in mice to examine the role of kinase activity of 
IRAK4 in TLR-mediated signaling pathways. The IRAK4 kinase–inactive knock-in mice were 
completely resistant to lipopolysaccharide (LPS)- and CpG-induced shock, due to impaired 
TLR-mediated induction of proinfl  ammatory cytokines and chemokines. Although inactiva-
tion of IRAK4 kinase activity did not affect the levels of TLR/IL-1R–mediated nuclear 
factor 𝗋B activation, a reduction of LPS-, R848-, and IL-1–mediated mRNA stability 
contributed to the reduced cytokine and chemokine production in bone marrow–derived 
macrophages from IRAK4 kinase–inactive knock-in mice. Both TLR7- and TLR9-mediated 
type I interferon production was abolished in plasmacytoid dendritic cells isolated from 
IRAK4 knock-in mice. In addition, infl  uenza virus–induced production of interferons 
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results indicate that IRAK4 kinase activity plays a critical role in TLR-dependent 
immune responses.
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interferon regulatory factor (IRF)5 and IRF7 and subsequent 
induction of IFN-α. It has been recently reported that the 
transcription factor IRF7 interacts with MyD88 to form a 
complex in the cytoplasm, and this interaction resulted in ac-
tivation of IFN-α–dependent promoters (25, 26). IRAK4, 
IRAK, and TRAF6 have also been implicated in this path-
way. In addition, the ubiquitin ligase activity of TRAF6 has 
been shown to mediate IRF7 activation (25–29). However, 
the detailed molecular mechanisms for this novel TLR7-, 
TLR8-, and TLR9-mediated MyD88-dependent pathway 
are still unclear.
One important question for the TLR-induced MyD88-
dependent pathway is the requirement of the kinase activity 
of IRAK4 in various signaling events. We have now gener-
ated IRAK4 kinase–inactive knock-in mice and found that 
the kinase activity of IRAK4 plays a critical role in TLR-
mediated immune responses. Our data indicate that inac-
tivation of IRAK4 kinase activity leads to reduced mRNA 
Figure 1.  Generation of IRAK4 kinase–inactive knock-in mice. 
(a) Domains of mouse IRAK4 protein. DD, death domain; UD, undetermined 
domain. K213/K214 were mutated to methionines in kinase-inactive 
knock-in mice. (b) Structure of the mouse IRAK4 gene, the targeting 
vector, and the targeted allele. Pr1 and Pr2 are primers used for 
genomic DNA PCR as described in c. (c) PCR analysis of IRAK4 genomic 
DNA in wild-type and IRAK4 kinase–inactive knock-in mice with Pr1 and 
Pr2. WT, wild-type; HET, heterozygote; KI, IRAK4 kinase–inactive knock-
in mice. (d) In the top panel, lysates from mouse embryo fi  broblasts 
from either WT or KI mice were left untreated or treated with IL-1β for 
5 min. IRAK4 was immunoprecipitated from whole cell lysates using a 
rabbit polyclonal antibody to full-length IRAK4 and assayed for its ability 
to phosphorylate recombinant kinase domain of IRAK1 (residues 182–546) 
by immunoprecipitation kinase assay as described in Materials and 
methods. Recombinant HIS-tagged IRAK4 protein (rIRAK4) was included 
as a control. In the bottom panel, Western blot analysis depicting 
IRAK4 expression levels in whole cell lysates described in Materials 
and methods.JEM VOL. 204, May 14, 2007  1027
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stability and diminished production of cytokines and chemo-
kines in response to LPS stimulation. Also, both TLR7- and 
TLR9-mediated cytokine production was abolished in BM-
derived macrophages from IRAK4 kinase–inactive knock-in 
mice. In addition to induction of proinfl  ammatory cytokines, 
TLR7- and TLR9-mediated signaling in plasmacytoid DCs 
(pDCs) has been shown to play a critical role in viral immu-
nity through the effi   cient production of type I interferons 
(26, 30, 31). Importantly, TLR7-, TLR9-, and infl  uenza virus–
mediated type I IFN production was also impaired in pDCs 
from IRAK4 kinase–inactive knock-in mice. Collectively, 
our results indicate that IRAK4 kinase activity plays a critical 
role in TLR-dependent immune responses.
RESULTS
The IRAK4 kinase–inactive knock-in mice are resistant 
to LPS- and CpG-induced shock
To determine the role of the kinase activity of IRAK4 in TLR-
mediated signaling, we generated IRAK4 kinase–inactive 
knock-in mice by mutating lysine 213 and 214 residues to 
methionines, which are part of the ATP-binding pocket of the 
kinase domain (Fig. 1, a–c). The inactivation of the kinase activ-
ity of the mutant IRAK4 from the knock-in mice was con-
fi  rmed by immunoprecipitation kinase assay in vitro (Fig. 1 d).
To examine the role of IRAK4 kinase activity in TLR-
mediated pathways, we compared the wild-type and IRAK4 
kinase–inactive knock-in mice for their susceptibility to LPS- 
and CpG-induced shock. IRAK4 kinase–inactive knock-in 
mice were completely resistant to LPS-induced septic shock 
(40 mg kg−1 body weight), whereas all of the wild-type mice 
died within 4 d of LPS challenge (Fig. 2 a). All wild-type 
mice injected intraperitoneally with a lethal dose of CpG 
(0.8 mg kg−1 and d-GalN 20 mg kg−1 body weight) died within 
24 h of challenge, whereas IRAK4 kinase–inactive knock-in 
mice were completely resistant to CpG-induced shock (Fig. 2 b). 
Consistent with the lethality curve, high levels of TNF-α 
and IL-6 were produced in the sera of wild-type mice in-
jected with LPS or CpG, whereas cytokine levels in the sera 
were signifi  cantly reduced in IRAK4 kinase–inactive knock-
in mice in response to LPS and CpG stimulation (Fig. 2, 
c and d). Cytokine levels in the sera were also signifi  cantly 
reduced in IRAK4 kinase–inactive knock-in mice injected 
Figure 2.  Resistance of IRAK4 kinase–inactive knock-in mice to 
LPS and CpG ODN-induced septic shock. (a) Age-matched wild-type 
(WT) and IRAK4 kinase–inactive knock-in (KI) mice (10 mice per group) 
were injected intraperitoneally with LPS (40 mg/kg body weight). Survival 
was monitored for 10 d. (b) Age-matched WT and KI mice (10 mice 
per group) were injected intraperitoneally with CpG ODN (0.8 mg/kg 
body weight) and D-GalN (20 mg). Survival was monitored for 10 d. 
(c) Serum concentration of TNF-α and IL-6 from WT and KI mice at 2 h 
after LPS injection was measured by ELISA. Results shown are the mean 
(± SD) of triplicate determinations. (d) Serum concentration of TNF-α 
and IL-6 from WT and KI mice at 2 h after CpG ODN injection was 
measured by ELISA. Results shown are the mean (± SD) of triplicate 
determinations. (e) Serum concentration of TNF-α and IL-6 from WT 
and KI mice at 2 h after IL-1β (40 μg/kg body weight) injection 
was measured by ELISA. Results shown are the mean (± SD) of 
triplicate determinations.1028  THE ROLE OF IRAK4 KINASE ACTIVITY IN TLR/IL-1R SIGNALING | Kim et al.
with IL-1 compared with that in wild-type mice (Fig. 2 e). 
Collectively, these results clearly indicate the critical role of 
the kinase activity of IRAK4 in IL-1R, TLR4, and TLR9 
signaling in vivo.
The kinase activity of IRAK4 is required for TLR-mediated 
cytokine and chemokine production
We then examined TLR-mediated cytokine production in pri-
mary cells from wild-type and IRAK4 kinase–inactive knock-
in mice. Cytokine (IL-6 and TNF-α) and chemokine (KC) 
production were signifi  cantly reduced in BM-derived macro-
phages from IRAK4 kinase–inactive knock-in mice in response 
to LPS, CpG, and R848 stimulation compared with that in 
wild-type cells (Fig. 3 a). IRAK4-defi  cient mice were used 
as a negative control. Although there was detectable residual 
cytokine and chemokine production in BM-derived macro-
phages from IRAK4 kinase–inactive knock-in mice in response 
to LPS stimulation, LPS-induced TNF-α, IL-6, and KC pro-
duction was almost completely abolished in BM-derived macro-
phages from IRAK4-defi  cient mice (Fig. 3 a). Furthermore, 
IL-1R–mediated cytokine and chemokine production were 
also severely impaired in BM-derived macrophages from 
IRAK4 kinase–inactive knock-in mice (Fig. 3 b).
We also examined the impact of IRAK4 kinase activity on 
cytokine and chemokine production mediated by other TLRs. 
Interestingly, we found that TLR2- and TLR5-mediated 
cytokine and chemokine production was greatly reduced in 
BM-derived macrophages from IRAK4 knock-in mice com-
pared with that in wild-type control cells, indicating that the 
kinase activity plays an important role in proinfl  ammatory 
cytokine production mediated by all of the TLRs that use 
the MyD88-dependent pathway (unpublished data). TLR3 
seems to be the only TLR that does not use the MyD88-
dependent pathway (32–34). TLR3-mediated cytokine pro-
duction was normal in IRAK4-defi  cient cells derived from 
human patients. TLR3-mediated cytokine production (IFN-α, 
IL-6, and TNF-α) was normal in myeloid DCs (mDCs) 
derived from IRAK4-defi  cient mice and IRAK4 kinase–
inactive knock-in mice compared with that in wild-type 
mice (Fig. 3 c). However, it is important to point out that a 
certain defect in TLR3-mediated cytokine production was 
detected previously in IRAK4-defi  cient mice, suggesting a 
Figure 3.  Impaired TLR-mediated cytokine and chemokine produc-
tion in macrophages from kinase–inactive IRAK4 knock-in mice. 
(a) Wild-type (WT), IRAK4 kinase–inactive knock-in (KI), or IRAK4 knock-out 
(KO) macrophages were treated with TLR ligands LPS (1 μg ml−1), R848 
(1 μg ml−1), or CpG ODN (4 μg ml−1) for 24 h. IL-6, KC, and TNF-α concen-
trations were measured by ELISA. Results shown are the means (± SD) of 
triplicate determinations. (b) WT or KI macrophages were treated with 
IL-1β (10 ng ml−1) for 24 h. IL-6 and KC concentrations were measured by 
ELISA. Results shown are the means (± SD) of triplicate determinations. 
(c) WT, KI, or KO mDCs were treated with TLR3 ligand, PolyIC (1 μg ml−1) 
for 24 h. IFN-α, IL-6, and TNF-α concentrations were measured by ELISA. 
Results shown are the means (± SD) of triplicate determinations.JEM VOL. 204, May 14, 2007  1029
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possible role of IRAK4 in TLR3 signaling directly or indi-
rectly, possibly by aff  ecting the expression levels of TLR3 in 
certain primary cells (18).
TLR7- and TLR9-mediated production of IFN-𝗂/𝗃 
was abolished in IRAK4 kinase–inactive pDCs
In addition to the induction of proinfl  ammatory  genes, 
TLR7- and TLR9-mediated signaling in pDCs has been 
shown to play a critical role in viral immunity through the 
effi   cient production of type I IFNs. In humans, it has been 
shown that TLR7-, TLR8-, and TLR9-mediated induction 
of IFN-α/β is strictly IRAK4 dependent. To examine the 
role of IRAK4 kinase activity in TLR7- and TLR9-medi-
ated IFN-α/β production, we generated Flt3 ligand–driven 
pDCs from the BM of IRAK4 kinase–inactive knock-in and 
wild-type mice. Importantly, we found that TLR7- and TLR9-
mediated IFN-α/β production was abolished in pDCs from 
IRAK4 knock-in mice, indicating that the kinase activity of 
IRAK4 is required for TLR7- and TLR9-mediated type I 
IFN production (Fig. 4 a). TLR7- and TLR9-mediated pro-
infl  ammatory cytokine production (IL-6, KC, and TNF-α) 
was also greatly reduced in pDCs from kinase-inactive IRAK4 
knock-in mice compared with that in wild-type pDCs (Fig. 
4 b). It is important to note that TLR7- and TLR9-mediated 
proinfl  ammatory cytokine production was completely abolished 
in IRAK4-defi  cient mice (Fig. 4 b), indicating that IRAK4 
kinase–inactive mutant still retained partial ability to confer 
TLR signaling.
We then examined the impact of kinase activity of IRAK4 
on viral-induced IFN production. pDCs were infected with 
infl  uenza virus, and IFN levels were monitored 24 h after 
infection. In addition to the observed defect in TLR7- and 
TLR9-mediated induction of IFNs, virus-mediated type I 
IFN production was also impaired in pDCs from IRAK4 
Figure 4.  Impaired TLR7- and TLR9-mediated type I IFN produc-
tion in pDCs derived from IRAK4 kinase–inactive knock-in mice. 
(a) Wild-type (WT) or IRAK4 kinase–inactive knock-in (KI) pDCs were stimu-
lated with R848 (1 μg ml−1) or CpG ODN (1 μg ml−1) for 24 h. IFN-α and 
IFN-β concentrations were measured by ELISA. Results shown are the 
means (± SD) of triplicate determinations. (b) WT, KI or IRAK4 knock-out 
(KO) pDCs were stimulated with R848 (1 μg ml−1) or CpG DNA (1 μg ml−1) 
for 24 h. IL-6, KC, and TNF-α concentrations were measured by ELISA. 
Results shown are the means (± SD) of triplicate determinations. 
Figure 5.  Impaired responses to type A infl  uenza virus in IRAK4 
kinase–inactive knock-in pDCs and mDCs. (a) Wild-type (WT) or IRAK4 
kinase–inactive knock-in (KI) pDCs were infected with type A infl  uenza virus 
(MOI = 2) for 24 h. IFN-α and IFN-β concentrations were measured by 
ELISA. Results shown are the means (± SD) of triplicate determinations. 
(b) WT or KI pDCs were infected with type A infl  uenza virus (MOI = 2) for 24 h. 
IL-6 and TNF-α concentrations were measured by ELISA. Results shown are 
the means (± SD) of triplicate determinations. (c and d) WT or KI pDCs were 
infected with type A infl  uenza virus (MOI = 2) for 24 h. pDCs were harvested 
and analyzed by quantitative real-time PCR (c) or Western blot analysis (d)
with antibody against infl  uenza virus NS1 and actin. (e) WT or KI mDCs were 
infected with type A infl  uenza virus (MOI = 2) for 24 h. IFN-α concentrations 
were measured by ELISA. Results shown are the means (± SD) of triplicate 
determinations. Mock, mock infected; INF, infected; ND, not detectable.1030  THE ROLE OF IRAK4 KINASE ACTIVITY IN TLR/IL-1R SIGNALING | Kim et al.
knock-in mice (Fig. 5 a). The production of IL-6 and TNF-α 
was also greatly reduced in the knock-in mice after infec-
tion with infl  uenza virus (Fig. 5 b). The fact that we detected 
viral NS1 mRNA and protein in both wild-type and IRAK4 
kinase–inactive knock-in pDCs infected with infl  uenza virus 
indicates that infection was successful in these cells (Fig. 5, 
c and d). It is important to note that NS1 expression was much 
higher in IRAK4 kinase–inactive knock-in cells compared 
with that in wild-type cells, which might be because of the 
impact of IFN production on the exclusion of infl  uenza virus 
in the wild-type cells (Fig. 5, c and d).
Interestingly, virus-induced IFN production in mDCs was 
independent of the IRAK4 kinase activity (Fig. 5 e). These re-
sults demonstrate that the kinase activity of IRAK4 is required 
for the TLR-mediated viral immune response in pDCs, but 
not involved in viral detection in mDCs, which is mediated 
by intracellular receptors RIG-I and MDA5 (35). Collectively, 
our results indicate that IRAK4 kinase activity plays a critical 
role in TLR-dependent immune responses, especially for TLR7- 
and TLR9-mediated production of type I IFN.
The IRAK4 kinase activity is partially required 
for TLR–IL-1R signaling
To study the direct impact of IRAK4 kinase activity on 
TLR-mediated signaling events, BM-derived macrophages 
from wild-type, IRAK4-deficient, and IRAK4 kinase–
inactive knock-in mice were examined for TLR-mediated 
NF-κB and JNK activation. LPS- and R848-induced JNK 
activation was greatly reduced in BM-derived macrophages 
from IRAK4 kinase–inactive knock-in and IRAK4-defi  cient 
mice compared with that in wild-type control cells (Fig. 6, 
a and g). Interestingly, LPS and R848 induced phosphoryla-
tion of ErK and IκB and NF-κB activation (including NF-
κB nuclear translocation and DNA binding activity) in both 
wild-type and IRAK4 kinase–inactive knock-in cells, despite 
the fact that these signaling events were greatly diminished in 
Figure 6.  Role of IRAK4 kinase activity in TLR-mediated signaling. 
(a) Cell lysates from BM-derived macrophages that were either untreated 
or treated with LPS (1 μg ml−1) or R848 (1 μg ml−1) for the indicated 
times were analyzed by Western blot analysis with antibodies against 
phospho–IκB-α, IκB-α, phospho-JNK, JNK, IRAK4, and actin. (b) Cell 
lysates from BM-derived macrophages that were either untreated or 
treated with LPS (1 μg ml−1) or R848 (1 μg ml−1) for the indicated times 
were analyzed by Western blot analysis with antibodies against phospho-
ERK, phospho-p38. (c) Nuclear extracts prepared from BM-derived mac-
rophages that were either untreated or treated with LPS (1 μg ml−1) 
or R848 (1 μg ml−1) for the indicated times were analyzed by Western 
blot analysis with antibodies against p65 and histone H3. (d) Cell lysates 
from BM-derived macrophages that were either untreated or treated 
with LPS (1 μg ml−1) or R848 (1 μg ml−1) for the indicated times were 
analyzed by electrophoretic mobility shift assay with a NF-κB–specifi  c 
probe. (e) Cell lysates from BM-derived macrophages that were either 
untreated or treated with IL-1β (10 ng ml−1) for the indicated times 
were analyzed by Western blot analysis with antibodies against phospho-
JNK, phospho–IκB-α, phosphor-p38, and actin. (f) Cell lysates from 
BM-derived macrophages that were either untreated or treated with 
IL-1β (10 ng ml−1) for the indicated times were analyzed electrophoretic 
mobility shift assay with a NF-κB–specifi  c probe. (g) Cell lysates from 
BM-derived macrophages of wild-type (WT) or IRAK4 knock-out (KO) 
mice that were either untreated or treated with LPS (1 μg ml−1) or R848 
(1 μg ml−1) for the indicated times were analyzed by Western blot analysis 
with antibodies against phospho-JNK, phospho–IκB-α, phospho-ERK, 
phospho-p38, and actin. (h) Nuclear extracts prepared from BM-
derived pDCs that were either untreated or treated with CpG for the 
indicated times were analyzed by Western blot analysis with antibodies 
against IRF7 and histone H3.JEM VOL. 204, May 14, 2007  1031
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BM-derived macrophages from IRAK4-defi  cient mice (Fig. 
6, a–d and g). However, it is important to point out that 
whereas LPS and R848 induced IκB phosphorylation and 
NF-κB activation in BM-derived macrophages from both 
wild-type and IRAK4 kinase–inactive knock-in mice, TLR-
mediated IκB degradation was attenuated in IRAK4 kinase–
inactive knock-in cells compared with that in wild-type cells 
(Fig. 6 a). The attenuated IκB degradation was probably 
responsible for the higher level of phosphorylated IκB detected 
in IRAK4 kinase–inactive knock-in cells 10 min after ligand 
stimulation compared with that in wild-type cells. We recently 
identifi  ed two TLR-mediated NF-κB activation pathways: 
TAK1-dependent and MEKK3-dependent (36).   Although 
NF-κB is activated by IκB phosphorylation and degradation 
in the TAK1-dependent pathway, IκB is phosphorylated, 
dissociated from NF-κB but not degraded in the MEKK3-
dependent pathway. We found that IRAK phosphorylation 
is required for IL-1–induced TAK1-dependent but not MEKK3-
dependent NF-κB activation, indicating that these two path-
ways bifurcate at the level of IRAK modifi  cation (36). The fact 
that LPS and R848 stimulation led to IκB phosphorylation, 
NF-κB activation but with attenuated IκB degradation in 
IRAK4 kinase–inactive knock-in cells suggests that the kinase 
activity of IRAK4 might play a more critical role in TLR/IL-
1R–induced TAK1-dependent than in the MEKK3-dependent 
NF-κB activation pathway.
LPS- and R848-induced p38 phosphorylation was nor-
mal in both IRAK4-defi  cient and IRAK4 kinase–inactive 
knock-in BM-derived macrophages, indicating that IRAK4 
is not required for TLR-mediated p38 phosphorylation (Fig. 
6, b and g). As a matter of fact, IRAK4-defi  cient cells had 
somewhat stronger LPS- and R848-mediated p38 activation. 
One possible explanation is that the loss of IRAK4 enhances 
TLR-signaling events independent of IRAK4, such as p38 
phosphorylation. We previously reported that both wild-
type IRAK4 and kinase-inactive IRAK4 mutant can restore 
IL-1–induced NF-κB and JNK activation in human IRAK4-
defi  cient cells (37). Consistent with our previous fi  ndings, we 
showed that IL-1 stimulation led to similar levels of phos-
phorylation of JNK, IκB, and p38 and NF-κB activation in 
BM-derived macrophages from wild-type and IRAK4 kinase–
inactive knock-in mice (Fig. 6, e and f).
We also examined IRF7 activation in pDCs in response 
to TLR9 ligand stimulation. As shown in Fig. 6 h, IRF7 
translocated into the nucleus 1 h after stimulation with CpG 
in wild-type pDCs, whereas TLR9-induced nuclear translo-
cation of IRF7 was abolished in IRAK4 kinase–inactive 
knock-in pDCs. These results indicate that the kinase activity 
of IRAK4 is required for TLR9-mediated IRF7 activation.
The IRAK4 kinase activity is required for a subset 
of cytokine and chemokine mRNA stability in response 
to LPS and R-848 stimulation
TLR–IL-1R–induced NF-κB and JNK activation were abol-
ished in IRAK4-defi   cient cells, resulting in the failure of 
TLR–IL-1R–mediated up-regulation of cytokine/chemokine 
mRNA and protein (18, 19) (Fig. 3 a, Fig. 4 b, and Fig. 7 a). 
It is important to point out that TLR–IL-1R–induced cyto-
kine/chemokine mRNA levels were signifi  cantly retained in 
IRAK4 kinase–inactive knock-in cells upon ligand stimulation 
compared with that in the wild-type cells (Fig. 7, b and f), 
which is consistent with the fact that the inactivation of IRAK4 
kinase activity did not reduce LPS-, R848-, and IL-1–mediated 
NF-κB activation (probably because of the redundancy of 
TAK1- versus MEKK3-dependent NF-κB activation path-
way). However, it was puzzling to note that LPS-, R848-, and 
IL-1–induced cytokine and chemokine production was greatly 
reduced in primary cells from IRAK4 kinase–inactive knock-
in mice and that these mice were completely resistant to LPS-
induced septic shock. Furthermore, in our previous study with 
human IRAK4-defi  cient cells, we reported that similar lev-
els of IL-1–induced NF-κB and JNK activation and IL-1–
induced IL-8 mRNA were detected in IRAK4-defi  cient cells 
reconstituted with IRAK4 kinase inactive mutant compared 
with that reconstituted with wild-type IRAK4. By ELISA 
analysis, we now found that IL-1–induced IL-8 and IL-6 pro-
duction was actually reduced in IRAK4-defi  cient cells recon-
stituted in IRAK4 kinase–inactive mutant compared with that 
reconstituted with wild-type IRAK4 (unpublished data).
Whereas TLR-mediated cytokine production was abol-
ished in BM-derived macrophages in IRAK4 kinase–inactive 
knock-in mice, TLR-induced NF-κB activation was normal. 
Therefore, we hypothesized that the kinase activity of IRAK4 
might be involved in the regulation of cytokine produc-
tion at a posttranscriptional level. To test this hypothesis, we 
designed experiments to measure the impact of IRAK4 
kinase activity on cytokine and chemokine mRNA stability. 
BM-derived macrophages from wild-type and IRAK4 ki-
nase–inactive knock-in mice were fi  rst treated with LPS for 
1.5 h, followed by treatment with actinomycin D (to block 
transcription) and LPS (for mRNA stabilization) for 0.5–4 h. 
Although both TNF-α and KC mRNAs were induced to 
similar levels in BM-derived macrophages from wild-type 
and IRAK4 kinase–inactive mice after the initial treatment 
with LPS (Fig. 7 b), the decay rate of mRNA was accelerated 
and reached a lower plateau for both messages in BM-derived 
macrophages from IRAK4 kinase–inactive mice compared 
with wild-type cells (Fig. 7, b and c). The impact of IRAK4 
kinase activity on mRNA stability was not limited to TLR4-
mediated signaling. Although TLR7-mediated KC and IL-6 
mRNA stability was abolished in BM-derived macrophages 
from IRAK4 kinase–inactive knock-in mice (Fig. 7, d and e), 
IL-1–mediated TNF-α and KC mRNA stability was also 
abolished in BM-derived macrophages from IRAK4 kinase–
inactive knock-in mice (Fig. 7 f and unpublished data). As a 
control, we showed that LPS- and R848-induced mRNAs 
(A20 and IκBα) that are not regulated at the RNA stability 
levels decayed at the similar rate in macrophages from IRAK4 
kinase–inactive knock-in mice to that in wild-type mice (Fig. 7, 
c and e). Collectively, these results indicate that the kinase 
activity of IRAK4 is required for a subset of TLR/IL-1R–
mediated cytokine and chemokine mRNA stability.1032  THE ROLE OF IRAK4 KINASE ACTIVITY IN TLR/IL-1R SIGNALING | Kim et al.
DISCUSSION
Previous studies showed that IRAK4 defi  ciency leads to se-
vere impairment of TLR signaling, indicating an essential 
role of IRAK4 in TLR-mediated pathways (18, 19). In this 
article, we report that the kinase activity of IRAK4 is critical 
for the functions of IRAK4 in TLR-mediated infl  ammatory 
and innate immune responses. It is clear that the kinase activity 
of IRAK4 is not only required for TLR (2, 4, 5, 7, and 9)-
induced production of proinfl  ammatory cytokines and che-
mokines but also necessary for TLR7- and TLR9-mediated 
Figure 7.  Impaired TLR-mediated mRNA stability in macrophages 
from kinase-inactive IRAK4 knock-in mice. (a) BM-derived macro-
phages from wild-type (WT) and IRAK4-defi  cient (KO) mice were untreated 
or treated with LPS (1 μg ml−1) or R848 (1 μg ml−1) for indicated times. 
Total RNA (3 μg) was subjected to RT-PCR analysis for the levels of 
IL-6, KC, and TNF-α mRNA. (b) BM-derived macrophages were untreated 
(NT) or treated with LPS (1 μg ml−1) for 90 min and then treated with 
actinomycin D (5 μg ml−1) and LPS (1 μg ml−1) for indicated times. Total 
RNA (10 μg) was subjected to Northern blot analysis to quantitate the 
levels of KC and TNF-α mRNA. (c) The autoradiographs in b were quantifi  ed 
for KC, TNF-α, and GAPDH mRNA levels using the NIH Image software 
package. Normalized levels of KC and TNF-α are depicted. Similar results 
were obtained in three separate experiments. A20 and IκBα mRNA from 
the same samples as described in b were also analyzed by quantitative 
RT-PCR, normalized by β-actin, and plotted. Similar results were obtained 
in three separate experiments. (d) BM-derived macrophages were 
untreated (NT) or treated with R-848 (1 μg ml−1) for 90 min and then 
treated with actinomycin D (5 μg ml−1) and R848 (1 μg ml−1) for indi-
cated times. Total RNA (10 μg) was subjected to Northern blot analysis to 
quantitate the levels of KC and TNF-α mRNA. (e) The autoradiographs in 
d were quantifi  ed for KC, TNF-α, and GAPDH mRNA levels using the NIH 
Image software package. Normalized levels of KC and TNF-α are depicted. 
Similar results were obtained in three separate experiments. A20 and 
IκBα mRNA from the samples as described in d were also analyzed by 
quantitative RT-PCR, normalized by β-actin, and plotted. Similar results 
were obtained in three separate experiments. (f) BM-derived macrophages 
were untreated (NT) or treated with IL-1 for 90 min and then treated with 
actinomycin D (5 μg ml−1) and IL-1 (1 ng ml−1) for indicated times. Total 
RNA (10 μg) was subjected to Northern blot analysis to quantitate the 
levels of KC mRNA.JEM VOL. 204, May 14, 2007  1033
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induction of IFN-α/β production. Moreover, infl  uenza virus–
mediated type I IFNs production was totally abolished in 
pDCs from IRAK4 knock-in mice. Collectively, our results 
indicate that IRAK4 kinase activity plays an essential role in 
TLR-dependent immune responses.
Previous studies suggest that IRAK4 is required for the 
recruitment and activation of IRAK at the signaling complex. 
Interestingly, IRAK4 kinase–inactive mutant had similar 
ability as the wild-type IRAK4 in restoring IL-1–mediated 
NF-κB in human IRAK4-defi  cient cells. Only the impair-
ment of the kinase activity of both IRAK and IRAK4 effi   -
ciently abolished the IL-1 pathway, suggesting that the kinase 
activity of IRAK and IRAK4 might be redundant for IL-1–
mediated signaling. On the other hand, by reconstituting 
IRAK4-deficient mouse embryonic fibroblasts, Lye et al. 
showed that the kinase activity of mouse IRAK4 is required 
for the optimal transduction of IL-1–induced signals, al-
though they found that IRAK4 is capable of mediating some 
NF-κB activation (38). In support of these previous fi  ndings, 
IL-1-, LPS-, and R848-induced NF-κB activation was not 
reduced in the BM-derived macrophages from IRAK4 kinase–
inactive knock-in mice compared with that in the wild-type 
control cells. Therefore, the kinase activity of IRAK4 seems to 
be dispensable for TLR/IL-1R–mediated NF-κB activation.
It is interesting to note that although TLR-mediated 
IκB and NF-κB activation was not reduced in BM-derived 
macrophages from IRAK4 kinase–inactive knock-in mice 
compared with that in wild-type mice, LPS- and R848-
mediated IκB degradation was attenuated in BM-derived 
macrophages from IRAK4 kinase–inactive knock-in mice, 
indicating that the requirement of IRAK4 kinase activity for 
certain aspects of TLR-mediated NF-κB activation. Such 
seemingly confl  icting results could probably be explained by 
the complexity of the TLR–IL-1R–mediated NF-κB activa-
tion pathways. Through the analyses of IRAK modifi  cation 
mutants, we recently uncovered two parallel IL-1–mediated 
signaling pathways for NF-κB activation: TAK1-dependent 
and MEKK3-dependent, respectively (36). These two path-
ways bifurcate at the level of IRAK modifi  cation.  The 
TAK1-dependent pathway leads to IκB kinase (IKK)-α/β 
phosphorylation and IKK-β activation, resulting in classical 
NF-κB activation through IκBα phosphorylation and degra-
dation. The TAK1-independent MEKK3-dependent path-
way involves IKK-γ phosphorylation and IKK-α activation, 
resulting in NF-κB activation through IκBα phosphoryla-
tion and subsequent dissociation from NF-κB but without 
IκBα degradation. These results provide new insight to our 
under  standing of NF-κB activation data from the IRAK4 
kinase–inactive knock-in cells. The fact that LPS and R848 
stimulation led to IκB phosphorylation, NF-κB activation 
but with attenuated IκB degradation in IRAK4 kinase–inactive 
knock-in cells suggests that the kinase activity of IRAK4 is 
likely to play a more critical role in TLR–IL-1R–induced 
TAK1-dependent than in the MEKK3-dependent NF-κB 
activation pathway. In support of this, our preliminary re-
sults showed that TLR–IL-1R–induced IKK-α/β and TAK1 
phosphorylation was indeed abolished in the absence of IRAK4 
kinase activity (unpublished data). Future studies are required 
to further investigate the role of IRAK4 kinase activity in the 
TAK1-dependent NF-κB activa  tion pathway.
It is intriguing that although IL-1R–mediated JNK activa-
tion was not reduced in the absence of IRAK4 kinase activity, 
TLR-mediated JNK activation was greatly reduced in IRAK4 
kinase–inactive knock-in cells. One possible   explanation 
is the diff  erential signaling events mediated by TLRs versus 
IL-1R. Although both IL-1R and TLRs use MyD88–IRAK4–
IRAK, the signaling outcomes are actually very diff  erent, in-
dicating the involvement of diff  erent downstream components 
in IL-1R versus TLR signaling. For example, TLR7 can me-
diate IFN production through the induction IRF7 activation 
(25), whereas IL-1R cannot. The diff  erential impact of IRAK4 
kinase activity on TLR- versus IL-1R–mediated JNK activa-
tion implicates distinct signaling events derived from TLRs 
and IL-1R in leading to JNK activation.
TLR–IL-1R–induced NF-κB and JNK activation were 
abolished in IRAK4-defi  cient cells, resulting in the failure of 
TLR–IL-1R–mediated up-regulation of cytokine/chemo-
kine mRNA and protein, probably because of a defect in gene 
transcription upon ligand stimulation (18, 19). Interestingly, 
we found that whereas inactivation of IRAK4 kinase activ-
ity did not reduce TLR–IL-1R–induced NF-κB activation 
and induction cytokine/chemokine mRNA, it did greatly 
diminish TLR–IL-1R–mediated induction of cytokines and 
chemokines. As a result, the IRAK4 kinase–inactive knock-
in mice were completely resistant to LPS-induced septic 
shock. Importantly, whereas TLR–IL-1R induced similar 
levels of cytokine and chemokine mRNA in the absence 
of IRAK4 kinase activity, TLR–IL-1R–mediated cytokine 
and chemokine mRNA stability was reduced in BM-derived 
macrophages from IRAK4 kinase–inactive knock-in mice. 
These observations suggest that posttranscriptional regula-
tion is at least one of the mechanisms responsible for the 
substantial reduction in TLR–IL-1R–mediated cytokine and 
chemokine production and the resistance to LPS-induced 
septic shock observed in these mice. One important question 
is whether the reduced JNK activation is linked to the re-
duction in mRNA stability in the absence of IRAK4 kinase 
activity. Interestingly, it has been reported that JNK plays 
a key role in IL-2 mRNA stability during T cell activation 
(39). However, whereas TLR–IL-1R–mediated JNK acti-
vation was completely abolished in TAK1-defi  cient mouse 
embryonic fi  broblasts (MEFs), LPS- and IL-1–mediated KC 
mRNA stabilization was not reduced compared with that 
in wild-type MEFs, indicating that JNK activation is not re-
quired for TLR–IL-1R–mediated mRNA stability (unpublished 
data). Furthermore, although dominant-negative mutant of 
TAK1 blocked TLR–IL-1R–mediated JNK activation, it 
did not aff  ect mRNA stability (unpublished data). These re-
sults suggest that the reduced TLR-mediated JNK activa-
tion may not be the cause for the abolished mRNA stability 
in IRAK4 kinase–inactive macrophages. Activation of p38 
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However, we found that LPS-induced p38 phosphorylation 
was normal in IRAK4 kinase–inactive knock-in and even 
IRAK4-defi  cient cells. Future studies are required to inves-
tigate the intermediate signaling events leading to mRNA 
stability and what role the kinase activity of IRAK4 might 
play in this process.
Earlier studies showed that TLR7 and TLR9 are the re-
ceptors responsible for the detection of viral infection in 
pDCs and mediate production of type I IFNs (31). We found 
that TLR7 and TLR9-mediated IFN production was com-
pletely abolished in pDCs derived from IRAK4 kinase–inac-
tive knock-in mice. The failure of infl  uenza virus to induce 
type I IFN production in pDCs derived from IRAK4 knock-
in mice indicates that the kinase activity of IRAK4 is required 
for TLR-mediated viral immunity.
MATERIALS AND METHODS
Reagents
Full-length HIS-tagged IRAK4 protein and kinase-dead IRAK1 (kinase 
domain) was expressed using bacculovirus and purifi   ed from SF9 cells. 
Recombinant human IL-1β was purchased from R&D Systems. CpG oli-
godeoxynucleotide (ODN) was purchased from Invivogen or IDEX. LPS 
(Escherichia coli 055:B5) was purchased from Sigma-Aldrich. R848 {1-(2-
hydroxy-2-methylpropyl)-2-methyl-1H-imidazo[4,5-c]quinolin-4-amine} 
was commercially synthesized by GLSynthesis. PolyI:C was purchased 
from GE Healthcare. Antibodies against phosphorylated IκB-α (Ser [32]) and 
JNK were purchased from Cell Signaling. Antibody to β-actin was purchased 
from Sigma-Aldrich. Affi   nity-purifi  ed polyclonal antiserum to full-length 
IRAK4 used for immunoprecipitation was generated at Zymed Labo-
ratories. IRAK4 antibody was also purchased from Upstate Biochemicals. 
Histone H3 (Cell Signaling, Technology, Inc.) and p65 (Cell Signaling, 
Technology, Inc.) were used to check the subcellular fractions.
Generation of the kinase-inactive IRAK4 knock-in mice
IRAK4 kinase–inactive knock-in mice were generated at InGenKO using 
C57BL/6 embryonic stem cells. A targeting construct containing lysines 
213 and 214 (in exon 4) changed to methionines in the ATP binding pocket 
of the kinase domain was generated for this purpose (Fig. 1 b). The com-
plete nucleotide sequence of the targeting construct is available upon 
request. Targeted embryonic stem cells were injected into mouse blastocysts 
to produce chimeric mice. The chimeric mice were bred to C57BL/6 (B6) 
mice to generate wild-type, heterozygous, and homozygous mice. IRAK4 
knock-in mice and their age-matched wild-type littermates from these in-
tercrosses were used for all experiments. The Cleveland Clinic Foundation 
Animal Research Committee approved all of the animal protocols used in 
this study.
Primary cell isolation
pDCs and mDCs. BM-derived macrophages were obtained from the BM of 
tibia and femur by fl  ushing with DMEM. BM cells were plated at 1 × 106 cells 
per ml in RPMI complete medium (10% FBS, 2 mM l-glutamine, 100 U/ml 
of penicillin, 100 μg/ml of streptomycin, and 50 μM β-mercaptoethanol) 
containing 100 ng/ml of Flt3L (PeproTec) for pDCs or 200 IU of GM-CSF 
(R&D Systems) for mDCs, respectively. pDCs and mDCs were collected for 
experiments after 6 d of culture.
Macrophages. BM-derived macrophages were obtained from the BM of 
tibia and femur by fl  ushing with DMEM. The cells were cultured in DMEM 
supplemented with 20% FBS, and 30% L929 supernatant for 5 d.
For IL-1β treatment, the cells were cultured in DMEM supplemented 
with 20% FBS and 10 ng/ml of murine M-CSF (PeproTech) for 5 d.
Northern blot and quantitative real-time PCR
For Northern analysis, total RNA was isolated using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instructions. RNA (10 μg) was 
fractionated by electrophoresis on a formaldehyde gel and transferred to 
  Hybond-N and probed with 32P-labeled gene-specifi  c DNA probes, accord-
ing to the procedures provided by GE Healthcare. Probe hybridization and 
washing were performed according to procedures provided by GE Health-
care, and signals were visualized by autoradiography.
For real-time PCR, total RNA was isolated using TRIzol reagent 
(Invitrogen). 3 μg of total RNA was then used for reverse transcription reac-
tion using SuperScript-reverse transcriptase (Invitrogen). Quantitative PCR 
was performed in AB 7300 RealTime PCR System, and the gene expression 
of mouse A20, IκBα, β-actin, and human infl  uenza virus NS1 was examined 
by SYBR GREEN PCR Master Mix (Applied Biosystems). PCR amplifi  cation 
was performed in triplicate, and water was used to replace cDNA in each run 
as a negative control. The reaction protocol included preincubation at 95°C 
to activate FastStart DNA polymerase for 10 min, amplifi  cation of 40 cycles 
that was set for 15 s at 95°C, and annealing for 60 s at 60°C. The results 
were normalized with the housekeeping gene mouse β-actin. The specifi  c 
pri  mer sequences used for mouse A20, mouse IκBα, mouse β-actin, mouse 
TNF-α, mouse IL-6, mouse KC, and infl  uenza virus NS1 (available from 
GenBank/EMBL/DDBJ under accession no. CY009640) listed as follows: 
A20 (103 bp): 5′-C  T  G  C  A  A  T  G  A  A  G  T  G  C  A  G  G  A  G  T  -3′ and 5′-G  T  G  T  G  G-
C  T  G  G  C  A  T  T  A  A  T  C  T  G  -3′; IκBα (104 bp): 5′-A  C  T  T  T  G  G  G  T  G  C  T  G  A  T  G-
T  C  A  A  -3′ and 5′-T  T  C  A  A  C  A  A  G  A  G  C  G  A  A  A  C  C  A  G  -3′; β-actin (133 bp): 
5′-G  G  T  C  A  T  C  A  C  T  A  T  T  G  G  C  A  A  C  G  -3′ and 5′-A  C  G  G  A  T  G  T  C  A  A  C  G  T-
C  A  C  A  C  T  -3′; TNF-α (103 bp): 5′-C  A  A  A  G  G  G  A  G  A  G  T  G  G  T  C  A  G  G  T  -3′ 
and 5′-A  T  T  G  C  A  C  C  T  C  A  G  G  G  A  A  G  A  G  T  -3′; IL-6 (127 bp): 5′-G  G  A  C  C  A-
A  G  A  C  C  A  T  C  C  A  A  T  T  C  -3′ and 5′-A  C  C  A  C  A  G  T  G  A  G  G  A  A  T  G  T  C  C  A  -3′; 
KC (125 bp): 5′-T  A  G  G  G  T  G  A  G  G  A  C  A  T  G  T  G  T  G  G  -3′ and 5′A  A  A  T  G  T  C-
C  A  A  G  G  G  A  A  G  C  G  T  -3′; infl  uenza virus NS1 (125 bp): 5′-C  T  A  A  G  G  G  C  T-
T  T  C  A  C  C  G  A  A  G  A  -3′ and 5′-T  T  C  C  A  T  T  C  A  A  G  T  C  C  T  C  C  G  A  T  -3′.
Western blot analysis
Cells stimulated as indicated were harvested, washed once with phosphate-
buff  ered saline, and lysed for 30 min at 4°C in 1.0% NP-40, 100 mM Tris 
hydrochloride, pH 8.0, 20% glycerol, and 0.2 mM EDTA. Cellular debris 
was removed by centrifugation at 10,000 × g for 5 min. For immunoblot-
ting, cell extracts were fractionated by sodium dodecyl sulfate-PAGE and 
transferred to Immobilon-P transfer membranes (Millipore), using a wet 
transfer apparatus (Bio-Rad Laboratories). Immunoblot analysis was per-
formed and the bands were visualized with horseradish peroxidase–coupled 
goat anti–rabbit, goat anti–mouse, or donkey anti–goat immunoglobulin as 
appropriate (Rockland), using the ECL chemiluminescence Western blot-
ting detection system (GE Healthcare). Protein levels were equilibrated with 
the Protein Assay Reagent (Bio-Rad Laboratories).
In vitro kinase assay
Lysates from MEF cells were prepared in a lysis buff  er consisting of 20 mM 
HEPES, pH 7.4, 150 mM NaCl, 1.5 mM MgCl2, 2 mM EGTA, 2 mM 
DTT, 0.5% Triton X-100, 12.5 mM β-glycerophosphate, 10 mM NaF, 
1 mM sodium orthovanadate, and protease inhibitors. IRAK4 was immuno-
precipitated using affi   nity-purifi  ed rabbit polyclonal antibody to full-length 
IRAK4 and protein A agarose beads. The resulting immunoprecipitates 
were incubated with 2 μM bacterially purifi  ed kinase domain of IRAK1 
(residues 182–546, predicted size 46 kd), in kinase buff  er consisting of 50 mM 
HEPES, pH 7.4, 5 mM MgCl2, 0.005% Triton X-100, 2.0 mM DTT, 200 μM 
cold ATP, and 2 μCi of [γ32P]-labeled ATP (3,000 Ci/mmol) in a total re-
action volume of 30 μl. Reactions were stopped by boiling and samples 
were analyzed by SDS-PAGE. Dried gels were analyzed by phosphorimaging.
Infl  uenza viral infection
Infection of pDCs and mDCs with infl  uenza A was performed as previously 
described (14). In brief, GM-CSF and FLT3 ligand–derived DCs were seeded 
on to 12-well plates at 5 × 105 cells/ml and infected with type A infl  uenza JEM VOL. 204, May 14, 2007  1035
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virus (multiplicity of infection [MOI] = 2) for 24 h. IFNs, proinfl  ammatory 
cytokine, nd chemokine production in the supernatants was measured 
by ELISA.
To check the infectivity of virus, infl  uenza virus NS1 protein or mRNA 
was analyzed by Western blot sis or quantitative real-time PCR using 
pDCs from wild-type and IRAK4 knock-in mice.
ELISA assay
Blood samples were collected from wild-type and IRAK4 knock-in mice 
after intraperitoneal injections of LPS at the concentration and time indi-
cated in Fig. 2 C. Cultures of pDCs and macrophages were stimulated 
with LPS (1 μg ml−1), CpD-ODN (1 μg ml−1), and R848 (1 μg ml−1) 
as indicated in Fig. 3 a, and collected after 24 h. IL-6, KC, and TNF-α 
production in culture medium was measured using ELISA kits obtained 
from R&D Systems, following manufacturer’s instructions. The ELISA 
kits for mouse IFN-α and IFN-β were purchased from PBL Biomedical 
Laboratories. Total protein concentration was measured by BCA analysis 
(Pierce Chemical Co.).
Preparation and fractionation of nuclear extracts
BM-derived macrophage from wild-type and IRAK4 kinase–inactive 
knock-in mice were cultured as indicated. After appropriate stimulation, 
cells were harvested, cell pellets were washed with ice-cold PBS twice and 
resuspended in 6 volumes of buff  er A (10 mM HEPES, pH 7.9, 1.5 mM 
MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM PMSF, 0.3 mM Na3VO4, 5 mM 
NaF) and allowed to sit on ice for 10 min. The cell suspension was trans-
ferred to the Dounce homogenizer, and the cells were disrupted with 30 
strokes. Cytoplasmic extracts were obtained by centrifugation at 500 g for 
1 min at 4°C. The nuclear pellet was washed with 1 ml Nuclei EZ Lysis buff  er 
(Sigma Nuclei EZ Prep kit) followed by washing with 1 ml buff  er A. Nuclei 
were recovered by centrifugation at 500 g for 1 min at 4°C and resuspended 
in 50 μl of buff  er B (20 mM HEPES, pH 7.9, 500 mM NaCl, 1.5 mM 
MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 1 mM PMSF, 0.3 mM Na3VO4, 
5 mM NaF) and incubated on ice for 30 min. After centrifugation for 10 min 
at 14,000 g, the supernatant fraction was collected.
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